<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Vortex Energy Corp. — News on 6ix</title>
<link>https://6ix.com/company/vortex-energy-corp</link>
<description>Latest news and press releases for Vortex Energy Corp. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 30 Apr 2026 12:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/vortex-energy-corp" rel="self" type="application/rss+xml" />
<item>
<title>Vortex Energy Announces Intent to Advance Next Phase of Technical Work at the Robinsons River Salt Project and Engages Lonquist</title>
<link>https://6ix.com/company/vortex-energy-corp/news/vortex-energy-announces-intent-to-advance-next-phase-of-technical-work-at-the-robinsons-river-salt-project-and-engages-lonquist</link>
<guid isPermaLink="true">https://6ix.com/company/vortex-energy-corp/news/vortex-energy-announces-intent-to-advance-next-phase-of-technical-work-at-the-robinsons-river-salt-project-and-engages-lonquist</guid>
<pubDate>Thu, 30 Apr 2026 12:00:00 GMT</pubDate>
<description>Data integration initiative aimed at refining subsurface model and advancing underground storage potential VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company”) is pleased to announce its intent to advance the next phase of technical work at its Robinsons River Salt Project (the "Project"), located approximately 35 kilometres south of Stephenville, Newfoundland and Labrador, and to announce that it has</description>
</item>
<item>
<title>Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells</title>
<link>https://6ix.com/company/vortex-energy-corp/news/biotechs-racing-to-translate-longevity-science-into-real-therapies-and-one-microcap-company-is-producing-an-anti-aging-protein-from-genetically-modified-encapsulated-cells</link>
<guid isPermaLink="true">https://6ix.com/company/vortex-energy-corp/news/biotechs-racing-to-translate-longevity-science-into-real-therapies-and-one-microcap-company-is-producing-an-anti-aging-protein-from-genetically-modified-encapsulated-cells</guid>
<pubDate>Fri, 10 Apr 2026 13:55:00 GMT</pubDate>
<description>Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is...</description>
</item>
<item>
<title>Vertex to Announce First Quarter 2026 Financial Results on May 4th</title>
<link>https://6ix.com/company/vortex-energy-corp/news/vertex-to-announce-first-quarter-2026-financial-results-on-may-4th</link>
<guid isPermaLink="true">https://6ix.com/company/vortex-energy-corp/news/vertex-to-announce-first-quarter-2026-financial-results-on-may-4th</guid>
<pubDate>Mon, 06 Apr 2026 20:00:00 GMT</pubDate>
<description>Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its first quarter 2026 financial...</description>
</item>
<item>
<title>Vertex Announces US FDA Approval for Label Extensions of ALYFTREK&#xAE; and TRIKAFTA&#xAE;, Expanding Availability of These Medicines to ~95% of All People With CF in the United States</title>
<link>https://6ix.com/company/vortex-energy-corp/news/vertex-announces-us-fda-approval-for-label-extensions-of-alyftrekandxae-and-trikaftaandxae-expanding-availability-of-these-medicines-to-95percent-of-all-people-with-cf-in-the-united-states</link>
<guid isPermaLink="true">https://6ix.com/company/vortex-energy-corp/news/vertex-announces-us-fda-approval-for-label-extensions-of-alyftrekandxae-and-trikaftaandxae-expanding-availability-of-these-medicines-to-95percent-of-all-people-with-cf-in-the-united-states</guid>
<pubDate>Wed, 01 Apr 2026 11:30:00 GMT</pubDate>
<description>-With this expansion, any variant that results in production of CFTR protein is now included in t...</description>
</item>
<item>
<title>Anti-Aging Protein Research Takes a Step Forward with Cell Cloning</title>
<link>https://6ix.com/company/vortex-energy-corp/news/anti-aging-protein-research-takes-a-step-forward-with-cell-cloning</link>
<guid isPermaLink="true">https://6ix.com/company/vortex-energy-corp/news/anti-aging-protein-research-takes-a-step-forward-with-cell-cloning</guid>
<pubDate>Tue, 24 Mar 2026 15:05:00 GMT</pubDate>
<description>Anti-Aging Protein Research Takes a Step Forward with Cell Cloning PR Newswire Iss...</description>
</item>
<item>
<title>Vertex Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults With IgA Nephropathy</title>
<link>https://6ix.com/company/vortex-energy-corp/news/vertex-announces-positive-week-36-interim-analysis-results-for-primary-and-all-secondary-endpoints-in-the-rainier-phase-3-trial-of-povetacicept-in-adults-with-iga-nephropathy-17</link>
<guid isPermaLink="true">https://6ix.com/company/vortex-energy-corp/news/vertex-announces-positive-week-36-interim-analysis-results-for-primary-and-all-secondary-endpoints-in-the-rainier-phase-3-trial-of-povetacicept-in-adults-with-iga-nephropathy-17</guid>
<pubDate>Mon, 09 Mar 2026 20:02:00 GMT</pubDate>
<description>- For the primary endpoint, patients treated with povetacicept achieved a 52.0% reduction from ...</description>
</item>
<item>
<title>Vertex to Present New Data on JOURNAVX&#xAE; That Demonstrates Effective Pain Management Following Aesthetic and Reconstructive Procedures</title>
<link>https://6ix.com/company/vortex-energy-corp/news/vertex-to-present-new-data-on-journavxandxae-that-demonstrates-effective-pain-management-following-aesthetic-and-reconstructive-procedures</link>
<guid isPermaLink="true">https://6ix.com/company/vortex-energy-corp/news/vertex-to-present-new-data-on-journavxandxae-that-demonstrates-effective-pain-management-following-aesthetic-and-reconstructive-procedures</guid>
<pubDate>Thu, 05 Mar 2026 15:00:00 GMT</pubDate>
<description>-Over 90% of patients in the study were opioid free through the end of multimodal treatment with ...</description>
</item>
<item>
<title>Vortex Energy Announces Postponement of AGM</title>
<link>https://6ix.com/company/vortex-energy-corp/news/vortex-energy-announces-postponement-of-agm</link>
<guid isPermaLink="true">https://6ix.com/company/vortex-energy-corp/news/vortex-energy-announces-postponement-of-agm</guid>
<pubDate>Wed, 18 Feb 2026 22:00:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company”) announces that, due to the absence of quorum at its February 13, 2026, Annual General Meeting (AGM), the holding of the AGM has been postponed. The Company will issue a news release once a new date and other details regarding the AGM have been determined. About Vortex Energy Corp. Vortex Energy Corp. is an exploration stage company engaged principally</description>
</item>
<item>
<title>Vertex to Participate in TD Cowen 46th Annual Health Care Conference on March 3</title>
<link>https://6ix.com/company/vortex-energy-corp/news/vertex-to-participate-in-td-cowen-46th-annual-health-care-conference-on-march-3-1</link>
<guid isPermaLink="true">https://6ix.com/company/vortex-energy-corp/news/vertex-to-participate-in-td-cowen-46th-annual-health-care-conference-on-march-3-1</guid>
<pubDate>Tue, 17 Feb 2026 21:00:00 GMT</pubDate>
<description>Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in ...</description>
</item>
<item>
<title>Vertex Reports Fourth Quarter and Full Year 2025 Financial Results</title>
<link>https://6ix.com/company/vortex-energy-corp/news/vertex-reports-fourth-quarter-and-full-year-2025-financial-results-1</link>
<guid isPermaLink="true">https://6ix.com/company/vortex-energy-corp/news/vertex-reports-fourth-quarter-and-full-year-2025-financial-results-1</guid>
<pubDate>Thu, 12 Feb 2026 21:01:00 GMT</pubDate>
<description>&#x2014; Full year total revenue of $12.0 billion, a 9% increase compared to full year 2024; four...</description>
</item>
<item>
<title>Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets</title>
<link>https://6ix.com/company/vortex-energy-corp/news/breaking-barriers-how-2026s-top-clinical-leaders-are-disrupting-chronic-disease-markets</link>
<guid isPermaLink="true">https://6ix.com/company/vortex-energy-corp/news/breaking-barriers-how-2026s-top-clinical-leaders-are-disrupting-chronic-disease-markets</guid>
<pubDate>Mon, 26 Jan 2026 15:16:00 GMT</pubDate>
<description>Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets ...</description>
</item>
<item>
<title>Vortex Energy Highlights 2025 Technical Milestones Across Project Portfolio and Announces Adjournment of AGM to February 13, 2026</title>
<link>https://6ix.com/company/vortex-energy-corp/news/vortex-energy-highlights-2025-technical-130000104</link>
<guid isPermaLink="true">https://6ix.com/company/vortex-energy-corp/news/vortex-energy-highlights-2025-technical-130000104</guid>
<pubDate>Wed, 21 Jan 2026 13:00:00 GMT</pubDate>
<description>Technical work completed at Robinsons River and Fire Eye supports next-stage exploration planningVANCOUVER, British Columbia, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company”) is pleased to provide a year-in-review summary of technical milestones achieved in 2025, along with a preview of the Company’s exploration plans for 2026. The Company also notes that its annual general meeting (AGM) has been adjourned to February 13, 2026,</description>
</item>
<item>
<title>Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th</title>
<link>https://6ix.com/company/vortex-energy-corp/news/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th</link>
<guid isPermaLink="true">https://6ix.com/company/vortex-energy-corp/news/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th</guid>
<pubDate>Tue, 20 Jan 2026 21:00:00 GMT</pubDate>
<description>Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year...</description>
</item>
<item>
<title>Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings</title>
<link>https://6ix.com/company/vortex-energy-corp/news/vertex-provides-pipeline-and-business-updates-in-advance-of-upcoming-investor-meetings</link>
<guid isPermaLink="true">https://6ix.com/company/vortex-energy-corp/news/vertex-provides-pipeline-and-business-updates-in-advance-of-upcoming-investor-meetings</guid>
<pubDate>Sun, 11 Jan 2026 22:00:00 GMT</pubDate>
<description>Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced business and program updates a...</description>
</item>
<item>
<title>Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize</title>
<link>https://6ix.com/company/vortex-energy-corp/news/gene-therapy-5-biotech-stocks-chasing-the-dollar36b-prize-1</link>
<guid isPermaLink="true">https://6ix.com/company/vortex-energy-corp/news/gene-therapy-5-biotech-stocks-chasing-the-dollar36b-prize-1</guid>
<pubDate>Fri, 02 Jan 2026 18:29:00 GMT</pubDate>
<description>Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize PR Newswire Issued on behal...</description>
</item>
<item>
<title>Vertex to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12</title>
<link>https://6ix.com/company/vortex-energy-corp/news/vertex-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-on-january-12</link>
<guid isPermaLink="true">https://6ix.com/company/vortex-energy-corp/news/vertex-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-on-january-12</guid>
<pubDate>Mon, 22 Dec 2025 21:00:00 GMT</pubDate>
<description>Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Dr. Reshma Kewalramani,...</description>
</item>
<item>
<title>From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes</title>
<link>https://6ix.com/company/vortex-energy-corp/news/from-insulin-injections-to-functional-cures-regenerative-medicine-reshapes-diabetes-1</link>
<guid isPermaLink="true">https://6ix.com/company/vortex-energy-corp/news/from-insulin-injections-to-functional-cures-regenerative-medicine-reshapes-diabetes-1</guid>
<pubDate>Tue, 16 Dec 2025 17:00:04 GMT</pubDate>
<description>VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Comm...</description>
</item>
<item>
<title>Vertex Presents New Data on CASGEVY&#xAE;, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions</title>
<link>https://6ix.com/company/vortex-energy-corp/news/vertex-presents-new-data-on-casgevyandxae-including-first-ever-data-in-children-ages-5-11-years-at-the-american-society-of-hematology-annual-meeting-and-announces-plan-for-global-regulatory-submissions</link>
<guid isPermaLink="true">https://6ix.com/company/vortex-energy-corp/news/vertex-presents-new-data-on-casgevyandxae-including-first-ever-data-in-children-ages-5-11-years-at-the-american-society-of-hematology-annual-meeting-and-announces-plan-for-global-regulatory-submissions</guid>
<pubDate>Sat, 06 Dec 2025 12:01:00 GMT</pubDate>
<description>- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell diseas...</description>
</item>
<item>
<title>Vertex to Participate in the Citi's 2025 Global Healthcare Conference on December 3</title>
<link>https://6ix.com/company/vortex-energy-corp/news/vertex-to-participate-in-the-citis-2025-global-healthcare-conference-on-december-3</link>
<guid isPermaLink="true">https://6ix.com/company/vortex-energy-corp/news/vertex-to-participate-in-the-citis-2025-global-healthcare-conference-on-december-3</guid>
<pubDate>Wed, 19 Nov 2025 21:00:00 GMT</pubDate>
<description>Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in ...</description>
</item>
<item>
<title>Vertex Presents Updated Phase 1/2 Data From RUBY-3 Study That Continue to Demonstrate Best-in-Class Potential for Povetacicept in Adults with IgA Nephropathy and Primary Membranous Nephropathy at American Society of Nephrology Kidney Week</title>
<link>https://6ix.com/company/vortex-energy-corp/news/vertex-presents-updated-phase-12-data-from-ruby-3-study-that-continue-to-demonstrate-best-in-class-potential-for-povetacicept-in-adults-with-iga-nephropathy-and-primary-membranous-nephropathy-at-american-society-of-nephrology-kidney-week</link>
<guid isPermaLink="true">https://6ix.com/company/vortex-energy-corp/news/vertex-presents-updated-phase-12-data-from-ruby-3-study-that-continue-to-demonstrate-best-in-class-potential-for-povetacicept-in-adults-with-iga-nephropathy-and-primary-membranous-nephropathy-at-american-society-of-nephrology-kidney-week</guid>
<pubDate>Sat, 08 Nov 2025 22:15:00 GMT</pubDate>
<description>- 48-week data show a 64% decrease from baseline in proteinuria in IgA nephropathy, 82% decreas...</description>
</item>
</channel>
</rss>